Skip to content

Public FDA record

Z-0166-2014: OmniPod Insulin Management Product Demonstration Kit; Model Reference Number: (PDK-ZXP490) Product Usage

Recall record Z-0166-2014 for Insulet Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0166-2014
Company in FDA record
Insulet Corporation
FDA classification date
Nov 5, 2013
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Alcohol Prep Pads contained within the kit are not properly labeled.

Source facts

Action
Insulet sent an Important Corrective Action Notification letter dated September 27, 2013 to all affected customers. The letter identified the affected product, problem and actions to be taken. Customers are asked to discontinue use and properly dispose of the affected product. For questions contact Customer Care at (866) 941-0294.
Initiated
2013-09-27
Root cause
Labeling design
Terminated
2014-03-04
Distribution
Worldwide Distribution - USA Nationwide and the country of Israel.
Recall number
Z-0166-2014
Recall status
Terminated
CDRH record ID
122397
FDA classified
2013-11-05
Recall event number
66425

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗